What will psychiatric practice look like in the year 2030?
The American Academy of Psychiatry and the Law hosted its first in-person meeting in October 2022. Check out these highlights.
In order to face the rapidly changing, increasingly complex, and globally connected world, we need to focus on the importance of early brain and child development.
What can you put on your plate this holiday season to keep your body and mind healthy?
While complete abstinence is a good goal, what other clinically meaningful endpoints are there for patients with substance use disorders? Learn more in this ACNP 2024 Annual Meeting session!
Medical student Liz Irvin discusses how storytelling is integral to her ability to stay sensitive when it comes to medicine and education, and shares a poem about an experience she had caring for others before starting medical school.
30% to 60% of individuals seeking treatment for SUD also meet criteria for PTSD.
In this CME article, examine how current DSM nosology defines the proper method of assessing a mixed-episode patient and which diagnostic labels to give them based on their presenting symptomatology.
A transdisciplinary team summarizes key points and reflections after 18 months of activity.
Which innovations can improve measurement, technology, investment, and public policy surrounding brain health?
Here are 5 reasons why we need to study the history of psychiatry.
"CT-R emphasizes the importance of hope while taking it a step further, turning hope into meaningful action and internalizing what success says about a person’s identity, strength, and ability to navigate future challenges."
If approved, how will MDMA-assisted therapy impact clinical psychiatry? The CEO of Lykos Therapeutics shares her thoughts.
“It is of the utmost importance to provide culturally competent forensic psychiatric services that are better suited to the needs of the African American community.”
How can digital therapeutics more readily be brought into the hands of patients with serious mental illnesses?
Panelists discuss how faster-acting treatments like zuranolone might improve patient outcomes and quality of life, the initial signs to monitor for assessing effectiveness, barriers to accessing such therapies in underserved populations and strategies to increase accessibility, approaches to ensuring safety while addressing distress in patients with intrusive thoughts, effective strategies for managing sleep issues in postpartum depression (PPD), advice for the psychiatry community when treating PPD, and how to tailor advice for clinicians working with underserved populations.
With the Super Bowl highlighting elite athletic performance, sports psychiatry is essential in strengthening athletes' mental resilience and well-being.
An expert offers a critical examination of the "slippery slope" argument.
Learn more about Alto Neuroscience's ALTO-300, in ongoing phase 2b trials as an adjunct treatment for major depressive disorder.
Understanding and addressing the unmet therapeutic needs of individuals living with mental health conditions.
What is the connection between ADHD diagnosis and a Western dietary pattern?
In this 2-part Special Report, we highlight the urgency of addressing child and adolescent mental health.
In advance of the June 4 FDA Advisory Committee Meeting on MDMA-assisted therapy, we sat down with Alejandra Alva, MD, to get his first impressions.
Seniors living independently have suffered isolation during the pandemic. What role can technology play in solving this?
With the growing elderly population and the prevalence of cognitive impairment, how can we protect older adults from financial scams?
A look at the association between cannabis use and schizophrenia, as well as the need for comprehensive public health policies and education.
Given that two-thirds of patients treated for a major depressive episode will fail to achieve remission of symptoms after 2 or more treatment trials of first-line antidepressants, the probability of remission will further decrease with subsequent medication trials. Treatment strategies for patients with TRD include augmentation, where a medication is added to a current antidepressant versus switching to a different antidepressant.
The Group for the Advancement of Psychiatry (America’s mental health think tank) calls for an end to the use of Title 42 to expel asylum seekers at the southern border. This policy places LGBTIQ asylum seekers in particular danger.
If Roe v Wade is overturned, how will patients with serious mental illness be affected?